Feasibility of prospective evaluation of first-line tyrosine kinase inhibition in patients with advanced now small cell lung cancer (NSCLC) harbouring a mutant EGFR gene

Jacques De Greve; J. Van Meerbeeck; J. Vansteenkiste; C. Focan; N. Fontaine; V. Meert; Denis Schallier; Pieter In 'T Veld; Erik Teugels

Feasibility of prospective evaluation of first-line tyrosine kinase inhibition in patients with advanced now small cell lung cancer (NSCLC) harbouring a mutant EGFR gene

Jacques De Greve, J. Van Meerbeeck, J. Vansteenkiste, C. Focan, N. Fontaine, V. Meert, Denis Schallier, Pieter In 'T Veld, Erik Teugels

Pathologische Anatomie

Onderzoeksoutput: Meeting abstract (Journal)

Samenvatting

No abstract available

Originele taal-2	English
Pagina's (van-tot)	47-47
Aantal pagina's	1
Tijdschrift	Annals of Oncology
Volume	18
Status	Published - 2007
Evenement	Unknown - Duur: 1 jan 2007 → …

Toegang tot document

http://apps.isiknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=4&SID=S27majJkIM2lPmM5F6n&page=1&doc=1&colname=WOS

Citeer dit

De Greve, J., Van Meerbeeck, J., Vansteenkiste, J., Focan, C., Fontaine, N., Meert, V., Schallier, D., In 'T Veld, P., & Teugels, E. (2007). Feasibility of prospective evaluation of first-line tyrosine kinase inhibition in patients with advanced now small cell lung cancer (NSCLC) harbouring a mutant EGFR gene. Annals of Oncology, 18, 47-47. http://apps.isiknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=4&SID=S27majJkIM2lPmM5F6n&page=1&doc=1&colname=WOS

De Greve, Jacques ; Van Meerbeeck, J. ; Vansteenkiste, J. ; Focan, C. ; Fontaine, N. ; Meert, V. ; Schallier, Denis ; In 'T Veld, Pieter ; Teugels, Erik. / Feasibility of prospective evaluation of first-line tyrosine kinase inhibition in patients with advanced now small cell lung cancer (NSCLC) harbouring a mutant EGFR gene. In: Annals of Oncology. 2007 ; Vol. 18. blz. 47-47.

@article{46657f4c096f46f38638f3cdf395b2fc,

title = "Feasibility of prospective evaluation of first-line tyrosine kinase inhibition in patients with advanced now small cell lung cancer (NSCLC) harbouring a mutant EGFR gene",

abstract = "No abstract available",

keywords = "KINASE INHIBITION",

author = "{De Greve}, Jacques and {Van Meerbeeck}, J. and J. Vansteenkiste and C. Focan and N. Fontaine and V. Meert and Denis Schallier and {In 'T Veld}, Pieter and Erik Teugels",

year = "2007",

language = "English",

volume = "18",

pages = "47--47",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

note = "null ; Conference date: 01-01-2007",

}

De Greve, J, Van Meerbeeck, J, Vansteenkiste, J, Focan, C, Fontaine, N, Meert, V, Schallier, D, In 'T Veld, P & Teugels, E 2007, 'Feasibility of prospective evaluation of first-line tyrosine kinase inhibition in patients with advanced now small cell lung cancer (NSCLC) harbouring a mutant EGFR gene', Annals of Oncology, vol. 18, blz. 47-47. <http://apps.isiknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=4&SID=S27majJkIM2lPmM5F6n&page=1&doc=1&colname=WOS>

Feasibility of prospective evaluation of first-line tyrosine kinase inhibition in patients with advanced now small cell lung cancer (NSCLC) harbouring a mutant EGFR gene. / De Greve, Jacques; Van Meerbeeck, J.; Vansteenkiste, J.; Focan, C.; Fontaine, N.; Meert, V.; Schallier, Denis; In 'T Veld, Pieter; Teugels, Erik.

In: Annals of Oncology, Vol. 18, 2007, blz. 47-47.

Onderzoeksoutput: Meeting abstract (Journal)

TY - JOUR

T1 - Feasibility of prospective evaluation of first-line tyrosine kinase inhibition in patients with advanced now small cell lung cancer (NSCLC) harbouring a mutant EGFR gene

AU - De Greve, Jacques

AU - Van Meerbeeck, J.

AU - Vansteenkiste, J.

AU - Focan, C.

AU - Fontaine, N.

AU - Meert, V.

AU - Schallier, Denis

AU - In 'T Veld, Pieter

AU - Teugels, Erik

PY - 2007

Y1 - 2007

N2 - No abstract available

AB - No abstract available

KW - KINASE INHIBITION

M3 - Meeting abstract (Journal)

VL - 18

SP - 47

EP - 47

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

Y2 - 1 January 2007

ER -

Feasibility of prospective evaluation of first-line tyrosine kinase inhibition in patients with advanced now small cell lung cancer (NSCLC) harbouring a mutant EGFR gene

Samenvatting

Toegang tot document

Vingerafdruk

Citeer dit